| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear receptor binding | 4.05e-06 | 187 | 131 | 9 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | UIMC1 NCOA6 PRRX1 MED14 STAT5B PPARGC1A ZBTB7A CTDP1 SMARCE1 TAF1 TAF1L | 9.72e-05 | 417 | 131 | 11 | GO:0061629 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | UIMC1 NCOA6 PRRX1 MED14 STAT5A STAT5B PPARGC1A ZBTB7A CTDP1 NUCKS1 SMARCE1 TAF1 TAF1L | 1.20e-04 | 582 | 131 | 13 | GO:0140297 |
| GeneOntologyMolecularFunction | transcription factor binding | UIMC1 NCOA6 PRRX1 MED14 STAT5A STAT5B PPARGC1A ZBTB7A CTDP1 ATXN3 EHMT1 NUCKS1 SMARCE1 TAF1 TAF1L | 1.27e-04 | 753 | 131 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYL3 MAP7D3 MAP1B CETN3 PACSIN3 FHOD3 JAKMIP3 MAPK8IP3 SPTBN4 PPARGC1A MTUS1 ANLN PLEKHG3 AATF TNNC1 UTRN EPB41L2 DMTN | 3.03e-04 | 1099 | 131 | 18 | GO:0008092 |
| GeneOntologyMolecularFunction | chromatin binding | NCOA6 STAG1 CHD8 SMARCAD1 STAT5B PPARGC1A ZC3H4 ACTR6 NUCKS1 SMARCE1 TAF1 TASOR TAF1L STAG3 | 3.59e-04 | 739 | 131 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | rRNA primary transcript binding | 4.22e-04 | 5 | 131 | 2 | GO:0042134 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 4.22e-04 | 5 | 131 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 7.19e-04 | 27 | 131 | 3 | GO:0001091 | |
| GeneOntologyMolecularFunction | actin binding | MYL3 MAP1B FHOD3 SPTBN4 ANLN PLEKHG3 TNNC1 UTRN EPB41L2 DMTN | 1.25e-03 | 479 | 131 | 10 | GO:0003779 |
| GeneOntologyMolecularFunction | spectrin binding | 1.42e-03 | 34 | 131 | 3 | GO:0030507 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 1.49e-03 | 9 | 131 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | PH domain binding | 1.49e-03 | 9 | 131 | 2 | GO:0042731 | |
| GeneOntologyMolecularFunction | p53 binding | 1.65e-03 | 77 | 131 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 1.68e-03 | 36 | 131 | 3 | GO:0140416 | |
| GeneOntologyMolecularFunction | rRNA binding | 1.82e-03 | 79 | 131 | 4 | GO:0019843 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.82e-03 | 37 | 131 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 2.18e-03 | 83 | 131 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | large ribosomal subunit rRNA binding | 2.26e-03 | 11 | 131 | 2 | GO:0070180 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | UIMC1 NCOA6 CETN3 SMARCAL1 MED14 GON4L GEMIN5 CHMP4BP1 CHD8 NCL SNUPN HEXIM1 STAT5A STAT5B EFTUD2 ZBTB7A RNF113B DDX46 CEBPZ ACTR6 SMARCE1 BOD1L1 TAF1 CPSF2 TAF1L EPB41L2 | 4.88e-07 | 1377 | 133 | 26 | GO:0140513 |
| GeneOntologyCellularComponent | histone methyltransferase complex | 1.17e-04 | 75 | 133 | 5 | GO:0035097 | |
| GeneOntologyCellularComponent | cytosolic ribosome | 1.43e-04 | 124 | 133 | 6 | GO:0022626 | |
| Domain | EF-hand-dom_pair | MYL3 CRACR2A CETN3 DTNB RYR1 STAT5A STAT5B EHD3 EHD2 PLCB1 PRKCSH TNNC1 UTRN | 8.09e-08 | 287 | 127 | 13 | IPR011992 |
| Domain | - | MYL3 CRACR2A CETN3 DTNB RYR1 STAT5A STAT5B EHD3 EHD2 PLCB1 TNNC1 UTRN | 2.23e-07 | 261 | 127 | 12 | 1.10.238.10 |
| Domain | ARM-type_fold | SMG1 STAG1 USP9X UBR4 FHOD3 HEATR5A FRYL USP9Y CEBPZ RRP12 STAG3 | 2.04e-05 | 339 | 127 | 11 | IPR016024 |
| Domain | TFIID_sub1_DUF3591 | 4.59e-05 | 2 | 127 | 2 | IPR022591 | |
| Domain | CAPS | 4.59e-05 | 2 | 127 | 2 | IPR033227 | |
| Domain | TBP-binding | 4.59e-05 | 2 | 127 | 2 | PF09247 | |
| Domain | DUF3591 | 4.59e-05 | 2 | 127 | 2 | PF12157 | |
| Domain | TAF_II_230-bd | 4.59e-05 | 2 | 127 | 2 | IPR009067 | |
| Domain | - | 4.59e-05 | 2 | 127 | 2 | 1.10.1100.10 | |
| Domain | Ribosomal_L12 | 4.59e-05 | 2 | 127 | 2 | IPR027534 | |
| Domain | TAF1_animal | 4.59e-05 | 2 | 127 | 2 | IPR011177 | |
| Domain | ARM-like | 9.68e-05 | 270 | 127 | 9 | IPR011989 | |
| Domain | EF_hand_dom | 1.89e-04 | 232 | 127 | 8 | IPR002048 | |
| Domain | SCD | 2.73e-04 | 4 | 127 | 2 | PS51425 | |
| Domain | SCD | 2.73e-04 | 4 | 127 | 2 | IPR020839 | |
| Domain | STAG | 2.73e-04 | 4 | 127 | 2 | PF08514 | |
| Domain | STAG | 2.73e-04 | 4 | 127 | 2 | IPR013721 | |
| Domain | EHD_N | 4.53e-04 | 5 | 127 | 2 | IPR031692 | |
| Domain | EHD_N | 4.53e-04 | 5 | 127 | 2 | PF16880 | |
| Domain | DUF1041 | 4.53e-04 | 5 | 127 | 2 | SM01145 | |
| Domain | PH | 6.34e-04 | 278 | 127 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 6.49e-04 | 279 | 127 | 8 | PS50003 | |
| Domain | PH_domain | 6.64e-04 | 280 | 127 | 8 | IPR001849 | |
| Domain | PH_dom-like | MCF2L2 SPTBN4 CADPS ANLN PLEKHG3 PLCB1 OSBPL10 PLD2 CADPS2 EPB41L2 | 6.69e-04 | 426 | 127 | 10 | IPR011993 |
| Domain | EF-hand_dom_typ1 | 6.76e-04 | 6 | 127 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 6.76e-04 | 6 | 127 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 6.76e-04 | 6 | 127 | 2 | PF09068 | |
| Domain | EF-hand_3 | 6.76e-04 | 6 | 127 | 2 | PF09069 | |
| Domain | STAT_TF_DNA-bd_sub | 9.42e-04 | 7 | 127 | 2 | IPR012345 | |
| Domain | STAT | 9.42e-04 | 7 | 127 | 2 | IPR001217 | |
| Domain | Munc13_1 | 9.42e-04 | 7 | 127 | 2 | IPR014770 | |
| Domain | STAT_int | 9.42e-04 | 7 | 127 | 2 | SM00964 | |
| Domain | MHD1 | 9.42e-04 | 7 | 127 | 2 | PS51258 | |
| Domain | STAT_TF_DNA-bd | 9.42e-04 | 7 | 127 | 2 | IPR013801 | |
| Domain | STAT_bind | 9.42e-04 | 7 | 127 | 2 | PF02864 | |
| Domain | STAT_int | 9.42e-04 | 7 | 127 | 2 | PF02865 | |
| Domain | - | 9.42e-04 | 7 | 127 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 9.42e-04 | 7 | 127 | 2 | PF01017 | |
| Domain | - | 9.42e-04 | 7 | 127 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 9.42e-04 | 7 | 127 | 2 | IPR013799 | |
| Domain | DUF1041 | 9.42e-04 | 7 | 127 | 2 | PF06292 | |
| Domain | STAT_TF_coiled-coil | 9.42e-04 | 7 | 127 | 2 | IPR015988 | |
| Domain | - | 9.42e-04 | 7 | 127 | 2 | 2.60.40.630 | |
| Domain | CAPS_dom | 9.42e-04 | 7 | 127 | 2 | IPR010439 | |
| Domain | WD40_repeat_dom | 9.73e-04 | 297 | 127 | 8 | IPR017986 | |
| Domain | PH | 9.78e-04 | 229 | 127 | 7 | PF00169 | |
| Domain | EF_HAND_2 | 1.03e-03 | 231 | 127 | 7 | PS50222 | |
| Domain | STAT_TF_alpha | 1.25e-03 | 8 | 127 | 2 | IPR013800 | |
| Domain | EF_Hand_1_Ca_BS | 1.26e-03 | 175 | 127 | 6 | IPR018247 | |
| Domain | SNF2_N | 1.32e-03 | 32 | 127 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.32e-03 | 32 | 127 | 3 | PF00176 | |
| Domain | SPEC | 1.32e-03 | 32 | 127 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.32e-03 | 32 | 127 | 3 | IPR018159 | |
| Domain | - | MCF2L2 SPTBN4 CADPS ANLN PLEKHG3 OSBPL10 PLD2 CADPS2 EPB41L2 | 1.42e-03 | 391 | 127 | 9 | 2.30.29.30 |
| Domain | EF-hand_4 | 1.99e-03 | 10 | 127 | 2 | PF12763 | |
| Domain | BROMODOMAIN_1 | 2.02e-03 | 37 | 127 | 3 | PS00633 | |
| Domain | C2 | 2.02e-03 | 131 | 127 | 5 | PF00168 | |
| Domain | Bromodomain | 2.18e-03 | 38 | 127 | 3 | PF00439 | |
| Domain | EH | 2.42e-03 | 11 | 127 | 2 | PS50031 | |
| Domain | EH | 2.42e-03 | 11 | 127 | 2 | SM00027 | |
| Domain | EH_dom | 2.42e-03 | 11 | 127 | 2 | IPR000261 | |
| Domain | C2 | 2.45e-03 | 137 | 127 | 5 | SM00239 | |
| Domain | - | 2.52e-03 | 40 | 127 | 3 | 4.10.1000.10 | |
| Domain | BROMODOMAIN_2 | 2.71e-03 | 41 | 127 | 3 | PS50014 | |
| Domain | EF_HAND_1 | 2.73e-03 | 204 | 127 | 6 | PS00018 | |
| Domain | C2 | 2.87e-03 | 142 | 127 | 5 | PS50004 | |
| Domain | Bromodomain | 2.90e-03 | 42 | 127 | 3 | IPR001487 | |
| Domain | BROMO | 2.90e-03 | 42 | 127 | 3 | SM00297 | |
| Domain | - | 2.90e-03 | 42 | 127 | 3 | 1.20.920.10 | |
| Domain | G_DYNAMIN_dom | 3.96e-03 | 14 | 127 | 2 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 3.96e-03 | 14 | 127 | 2 | PS51718 | |
| Domain | ZnF_C3H1 | 4.25e-03 | 48 | 127 | 3 | SM00356 | |
| Domain | Dynamin_GTPase | 4.55e-03 | 15 | 127 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 4.55e-03 | 15 | 127 | 2 | IPR022812 | |
| Domain | Dynamin_N | 4.55e-03 | 15 | 127 | 2 | PF00350 | |
| Domain | C2_dom | 5.28e-03 | 164 | 127 | 5 | IPR000008 | |
| Domain | Helicase_C | 6.14e-03 | 107 | 127 | 4 | PF00271 | |
| Domain | HELICc | 6.14e-03 | 107 | 127 | 4 | SM00490 | |
| Domain | Helicase_C | 6.34e-03 | 108 | 127 | 4 | IPR001650 | |
| Domain | ZF_ZZ_2 | 6.54e-03 | 18 | 127 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 6.54e-03 | 18 | 127 | 2 | PS01357 | |
| Domain | ZZ | 6.54e-03 | 18 | 127 | 2 | PF00569 | |
| Domain | HELICASE_CTER | 6.55e-03 | 109 | 127 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 6.55e-03 | 109 | 127 | 4 | PS51192 | |
| Domain | DEXDc | 6.55e-03 | 109 | 127 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 6.76e-03 | 110 | 127 | 4 | IPR014001 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | SMG1 RPLP0 RPLP1 RPLP2 CNOT10 BMS1 GEMIN5 PSMD3 NCL SNUPN EFTUD2 RNF113B DDX46 LTV1 CPSF2 | 1.99e-05 | 612 | 98 | 15 | MM15547 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UIMC1 NCOA6 CAAP1 RPLP0 MED14 NASP GEMIN5 NCL ZC3H18 SMARCAD1 MAPK8IP3 EFTUD2 ZBTB7A DDX46 MDN1 ZC3H4 ANLN PHF3 RRP12 CTDP1 NUCKS1 CPSF2 EPB41L2 | 3.04e-14 | 774 | 134 | 23 | 15302935 |
| Pubmed | RPLP0 RPLP1 MAP1B RPLP2 USP9X UBR4 BMS1 MAK16 GEMIN5 CHD8 NCL FRYL ZC3H18 DDX46 MDN1 CEBPZ PHF3 RRP12 AATF UTRN EPB41L2 | 9.79e-14 | 653 | 134 | 21 | 22586326 | |
| Pubmed | UIMC1 EAPP RTF2 SMARCAL1 UBR4 MED14 WDR55 GEMIN5 PSMD3 CHD8 NCL ZC3H18 SMARCAD1 HEXIM1 EHD2 DDX46 MDN1 PHF3 EHMT1 NUCKS1 SMARCE1 BOD1L1 CAVIN1 TAF1 CPSF2 | 1.35e-13 | 1014 | 134 | 25 | 32416067 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | UIMC1 NCOA6 CAAP1 SALL3 RPLP0 MAP7D3 MAP1B RPLP0P6 RTF2 CHD8 NCL ZC3H18 EFTUD2 DDX46 CEBPZ ZC3H4 ANLN PHF3 SMARCE1 AATF BOD1L1 TAF1 TASOR TAF1L | 2.87e-13 | 954 | 134 | 24 | 36373674 |
| Pubmed | UIMC1 CAAP1 CNOT10 BMS1 MED14 PACSIN3 MAK16 WDR55 DNAJC21 GON4L GEMIN5 CHD8 HEXIM1 ZBTB7A DDX46 MDN1 CEBPZ ANLN PHF3 PLEKHG3 RRP12 EHMT1 SMARCE1 AATF CPSF2 TASOR TAF1L UTRN EPB41L2 | 4.90e-13 | 1497 | 134 | 29 | 31527615 | |
| Pubmed | RPLP1 RPLP2 USP9X RPS6KB1 NASP GEMIN5 CHD8 NCL STAT5B ZC3H4 ANLN PHF3 RRP12 CTDP1 NUCKS1 STK39 CDC25C EPB41L2 | 1.11e-12 | 503 | 134 | 18 | 16964243 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | UIMC1 USP9X UBR4 GEMIN5 CHD8 NCL SMARCAD1 EFTUD2 MDN1 ANLN PHF3 EHMT1 BOD1L1 TAF1 CPSF2 | 3.57e-12 | 332 | 134 | 15 | 32786267 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPLP0 RPLP1 RPLP2 USP9X UBR4 BMS1 MAK16 NASP GEMIN5 PSMD3 NCL SMARCAD1 HEXIM1 EFTUD2 MDN1 CEBPZ RRP12 NEMF EHMT1 NUCKS1 CC2D2A SMARCE1 BOD1L1 LTV1 PRKCSH PEAK1 EPB41L2 | 5.92e-12 | 1425 | 134 | 27 | 30948266 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MAP1B USP9X UBR4 BMS1 PACSIN3 NASP GEMIN5 NCL FRYL ZC3H18 HEXIM1 EFTUD2 DDX46 MTUS1 ANLN RRP12 ATXN3 OSBPL10 NUCKS1 PPME1 SMARCE1 AATF STK39 CAVIN1 PRKCSH UTRN | 1.43e-11 | 1367 | 134 | 26 | 32687490 |
| Pubmed | NCOA6 MAP7D3 MAP1B USP9X MED14 NASP GEMIN5 CHD8 DDX46 SYNJ1 CEBPZ ANLN PHF3 SMARCE1 BOD1L1 TAF1 PEAK1 | 4.72e-11 | 549 | 134 | 17 | 38280479 | |
| Pubmed | SMG1 DMXL2 MIA3 MAP1B RPS6KB1 DNAJC21 GON4L CC2D1B CHD8 NCL SMARCAD1 HEXIM1 STAT5B ZC3H4 NEMF OSBPL10 CLSPN TASOR | 7.52e-11 | 650 | 134 | 18 | 38777146 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | UIMC1 RPLP0 MAP7D3 RPLP1 MAP1B NASP GEMIN5 NCL EFTUD2 DDX46 SYNJ1 ZC3H4 RRP12 NUCKS1 PPME1 SMARCE1 BOD1L1 LTV1 TASOR UTRN EPB41L2 | 8.17e-11 | 934 | 134 | 21 | 33916271 |
| Pubmed | SMG1 NCOA6 DMXL2 CHD8 ADCY9 CEP68 SYNJ1 CADPS ZC3H4 PHF3 EHMT1 PLCB1 | 8.43e-11 | 225 | 134 | 12 | 12168954 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | NCOA6 CAAP1 BMS1 NASP CHD8 NCL ZC3H18 DDX46 ZC3H4 PHF3 BOD1L1 TAF1 TAF1L | 8.56e-11 | 283 | 134 | 13 | 30585729 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 MAP7D3 MAP1B RPLP2 FRYL CDC14A STK3 MDN1 SYNJ1 MTUS1 ANLN PHF3 PLEKHG3 OSBPL10 BOD1L1 PEAK1 CDC25C UTRN EPB41L2 DMTN | 1.37e-10 | 861 | 134 | 20 | 36931259 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EAPP RPLP0 RPLP1 RPLP2 USP9X RTF2 UBR4 PACSIN3 GEMIN5 PSMD3 NCL ZC3H18 SMARCAD1 HEXIM1 EFTUD2 DDX46 MIA2 CEBPZ ZC3H4 RRP12 NEMF SMARCE1 LTV1 CAVIN1 EPB41L2 | 1.75e-10 | 1415 | 134 | 25 | 28515276 |
| Pubmed | RPLP0 RPLP2 BMS1 PACSIN3 NCL ZC3H18 HEXIM1 EFTUD2 DDX46 MDN1 CEBPZ ZC3H4 PHF3 RRP12 EHMT1 SMARCE1 AATF CAVIN1 TASOR | 7.35e-10 | 847 | 134 | 19 | 35850772 | |
| Pubmed | DMXL2 STAG1 USP9X UBR4 MCF2L2 FBXW4 NASP SMARCAD1 JAKMIP3 USP9Y BRWD3 STAT5B MAPK8IP3 SPTBN4 MIA2 SYNJ1 CADPS NEMF PPME1 SMARCE1 TAF1 CADPS2 UTRN | 8.11e-10 | 1285 | 134 | 23 | 35914814 | |
| Pubmed | DMXL2 MIA3 USP9X RPS6KB1 UBR4 CHD8 NCL JAKMIP3 MAPK8IP3 EHD3 EFTUD2 SPTBN4 KCNA1 MDN1 SYNJ1 ZC3H4 EHMT1 PLCB1 CPSF2 EPB41L2 | 9.49e-10 | 963 | 134 | 20 | 28671696 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CAAP1 RPLP0 RPLP1 RPLP2 UBR4 BMS1 MAK16 NASP GEMIN5 PSMD3 CHD8 NCL STAT5A EFTUD2 RABL6 DDX46 MDN1 CEBPZ RRP12 PPME1 AATF LTV1 CPSF2 | 1.32e-09 | 1318 | 134 | 23 | 30463901 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPLP0 RPLP1 RPLP2 BMS1 MAK16 NASP PSMD3 NCL HEXIM1 EFTUD2 MDN1 CEBPZ ZC3H4 ANLN PHF3 RRP12 AATF BOD1L1 CAVIN1 CLSPN | 1.50e-09 | 989 | 134 | 20 | 36424410 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | UIMC1 MAP7D3 RPLP1 RPLP2 NCL ZC3H18 EFTUD2 MTUS1 CEBPZ ZC3H4 ANLN PEAK1 EPB41L2 | 1.67e-09 | 361 | 134 | 13 | 30344098 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 MIA3 RPLP0 RPLP2 USP9X MED14 GEMIN5 CHD8 NCL CEBPZ PHF3 ACTR6 RRP12 AATF | 1.89e-09 | 440 | 134 | 14 | 34244565 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPLP0 MAP7D3 RPLP1 RPLP2 BMS1 PACSIN3 MAK16 DNAJC21 PSMD3 NCL ZC3H18 EFTUD2 CEBPZ ANLN PHF3 PLEKHG3 RRP12 AATF LTV1 CAVIN1 EPB41L2 DMTN | 2.98e-09 | 1257 | 134 | 22 | 36526897 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | MAP1B GON4L CHD8 ZC3H18 MDN1 ACTR6 RRP12 AATF PRKCSH TAF1 CPSF2 UTRN EPB41L2 | 4.77e-09 | 394 | 134 | 13 | 27248496 |
| Pubmed | UIMC1 SMG1 NCOA6 USP9X CNOT10 UBR4 BMS1 GON4L PSMD3 CHD8 ZC3H18 STAT5A STAT5B ZBTB7A ACTR6 RRP12 EHMT1 SMARCE1 LTV1 PRKCSH TAF1 CPSF2 TAF1L | 6.05e-09 | 1429 | 134 | 23 | 35140242 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAP7D3 MAP1B BMS1 MED14 MAK16 DNAJC21 PSMD3 NCL DDX46 MDN1 CEBPZ PHF3 RRP12 NEMF AATF LTV1 TASOR | 6.34e-09 | 759 | 134 | 17 | 35915203 |
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | RPLP0 RPLP0P6 UBR4 MED14 PSMD3 NCL DDX46 TAF1 CPSF2 TAF1L EPB41L2 | 8.58e-09 | 269 | 134 | 11 | 29511261 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPLP0 MAP1B RPLP2 USP9X PACSIN3 PSMD3 NCL EFTUD2 DDX46 MDN1 CEBPZ ZC3H4 PLEKHG3 RRP12 AATF PRKCSH CPSF2 UTRN EPB41L2 | 1.59e-08 | 1024 | 134 | 19 | 24711643 |
| Pubmed | MIA3 DTNB USP9X BMS1 WDR55 PSMD3 CDC14A ADCY9 MTUS1 CEBPZ RRP12 NUCKS1 PPME1 AATF PRKCSH PEAK1 CPSF2 CDC25C UTRN | 2.33e-08 | 1049 | 134 | 19 | 27880917 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | UIMC1 NCOA6 MAP7D3 RPLP1 RPLP2 NCL ZC3H18 EFTUD2 ZBTB7A DDX46 MDN1 CEBPZ PHF3 ACTR6 RRP12 EHMT1 SMARCE1 AATF CPSF2 TASOR TAF1L | 2.61e-08 | 1294 | 134 | 21 | 30804502 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | UIMC1 MIA3 RPLP1 RPLP2 USP9X NASP GEMIN5 PSMD3 NCL EFTUD2 MDN1 NUCKS1 BOD1L1 LTV1 PRKCSH UTRN EPB41L2 | 3.14e-08 | 847 | 134 | 17 | 35235311 |
| Pubmed | UIMC1 SMG1 RPLP0 RPLP1 STAG1 MAP1B DTNB UBR4 DNAJC21 PSMD3 CC2D1B NCL SPTBN4 MDN1 MIA2 CEBPZ CTAGE1 CC2D2A AATF BOD1L1 CADPS2 TASOR | 3.48e-08 | 1442 | 134 | 22 | 35575683 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CAAP1 DMXL2 RPLP0 MAP1B RPLP2 BMS1 MED14 NCL ZC3H18 USP9Y EFTUD2 DDX46 ZC3H4 RRP12 NEMF EHMT1 NUCKS1 SMARCE1 CPSF2 | 3.79e-08 | 1082 | 134 | 19 | 38697112 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RPLP0 RPLP1 RPLP2 USP9X UBR4 NASP GEMIN5 PSMD3 CC2D1B NCL FRYL SMARCAD1 HEXIM1 STAT5B EFTUD2 RABL6 NUCKS1 PPME1 STK39 LTV1 PRKCSH EPB41L2 | 4.08e-08 | 1455 | 134 | 22 | 22863883 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAP1B RPLP2 RTF2 UBR4 BMS1 GEMIN5 PSMD3 CHD8 NCL SMARCAD1 EFTUD2 MDN1 CEBPZ ANLN PLEKHG3 RRP12 AATF LTV1 CAVIN1 UTRN EPB41L2 | 5.55e-08 | 1353 | 134 | 21 | 29467282 |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 23400861 | ||
| Pubmed | Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors. | 5.59e-08 | 3 | 134 | 3 | 21040949 | |
| Pubmed | The subcellular distribution of the human ribosomal "stalk" components: P1, P2 and P0 proteins. | 5.59e-08 | 3 | 134 | 3 | 12479870 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 10856704 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 3323886 | ||
| Pubmed | Disruption of the ribosomal P complex leads to stress-induced autophagy. | 5.59e-08 | 3 | 134 | 3 | 26176264 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 STAG1 SMARCAL1 UBR4 MED14 CHD8 ZC3H18 SMARCAD1 DDX46 ZC3H4 CPSF2 | 9.64e-08 | 341 | 134 | 11 | 32971831 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPLP0 RPLP1 MAP1B RPLP2 USP9X UBR4 NASP GEMIN5 PSMD3 NCL EFTUD2 DDX46 MDN1 ZC3H4 RRP12 NEMF NUCKS1 PRKCSH EPB41L2 | 9.67e-08 | 1149 | 134 | 19 | 35446349 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | RPLP0 RPLP1 RPLP2 BMS1 NCL ZC3H18 EFTUD2 DDX46 MDN1 CEBPZ RRP12 SMARCE1 AATF CPSF2 | 1.01e-07 | 605 | 134 | 14 | 28977666 |
| Pubmed | 1.12e-07 | 147 | 134 | 8 | 29576527 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.18e-07 | 148 | 134 | 8 | 32538781 | |
| Pubmed | CAAP1 RPLP0 RPLP1 RPLP2 USP9X BMS1 GEMIN5 NCL ZC3H18 HEXIM1 EFTUD2 ZC3H4 RRP12 LTV1 CPSF2 | 1.18e-07 | 713 | 134 | 15 | 29802200 | |
| Pubmed | RPLP0 RPLP1 RPLP2 USP9X BMS1 DNAJC21 NCL HEXIM1 EFTUD2 RRP12 NEMF CTDP1 SMARCE1 CPSF2 | 1.23e-07 | 615 | 134 | 14 | 31048545 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | UIMC1 CAAP1 MYL3 RPLP0 MAP7D3 RPLP1 RPLP2 RPLP0P6 DNAJC21 NCL EFTUD2 DDX46 CEBPZ PLEKHG3 RRP12 AATF CAVIN1 | 1.59e-07 | 949 | 134 | 17 | 36574265 |
| Pubmed | 1.67e-07 | 215 | 134 | 9 | 35973513 | ||
| Pubmed | SMG1 NCOA6 MAP7D3 USP9X SMARCAL1 UBR4 RYR1 C17orf75 MDN1 EHMT1 PLCB1 SMARCE1 AATF LTV1 | 1.92e-07 | 638 | 134 | 14 | 31182584 | |
| Pubmed | SMG1 RPLP0 RPLP1 RPLP2 USP9X BMS1 NASP DNAJC21 PSMD3 NCL ZC3H18 EFTUD2 CEBPZ ZC3H4 LTV1 CPSF2 CLSPN | 2.19e-07 | 971 | 134 | 17 | 33306668 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 2.47e-07 | 163 | 134 | 8 | 22113938 | |
| Pubmed | 2.79e-07 | 300 | 134 | 10 | 28561026 | ||
| Pubmed | CAAP1 CHD8 ZC3H18 SMARCAD1 BRWD3 ADCY9 ZBTB7A MTUS1 CADPS ZC3H4 ACTR6 EHMT1 SMARCE1 STK39 CAVIN1 TAF1 CSMD1 CLSPN | 3.12e-07 | 1116 | 134 | 18 | 31753913 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | STAG1 USP9X UBR4 PACSIN3 CHD8 RABL6 DDX46 SYNJ1 CADPS NEMF PLCB1 NUCKS1 | 3.43e-07 | 475 | 134 | 12 | 31040226 |
| Pubmed | MAP7D3 RPLP2 TMEM115 BMS1 NCL ADCY9 EFTUD2 RABL6 ZC3H4 EHMT1 OSBPL10 PEAK1 CLSPN TASOR EPB41L2 | 3.52e-07 | 777 | 134 | 15 | 35844135 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | EAPP STAG1 CETN3 CNOT10 PACSIN3 EFTUD2 STK3 DDX46 ZC3H4 ANLN RRP12 EHMT1 PPME1 SMARCE1 LTV1 CAVIN1 PRKCSH CDC25C | 5.13e-07 | 1155 | 134 | 18 | 20360068 |
| Pubmed | cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. | 5.56e-07 | 5 | 134 | 3 | 12839582 | |
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 5.56e-07 | 5 | 134 | 3 | 15183315 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SMG1 DMXL2 RPLP1 STAG1 MAP1B USP9X UBR4 PSMD3 NCL CADPS RRP12 BOD1L1 | 5.66e-07 | 498 | 134 | 12 | 36634849 |
| Pubmed | Serological detection of cutaneous T-cell lymphoma-associated antigens. | 6.18e-07 | 18 | 134 | 4 | 11149944 | |
| Pubmed | RPLP0 RPLP1 NASP DDX46 SYNJ1 ZC3H4 ANLN PHF3 NUCKS1 SMARCE1 BOD1L1 UTRN | 6.69e-07 | 506 | 134 | 12 | 30890647 | |
| Pubmed | 7.63e-07 | 335 | 134 | 10 | 15741177 | ||
| Pubmed | 8.50e-07 | 339 | 134 | 10 | 30415952 | ||
| Pubmed | The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression. | 9.29e-07 | 84 | 134 | 6 | 26299517 | |
| Pubmed | 1.04e-06 | 136 | 134 | 7 | 26979993 | ||
| Pubmed | 1.06e-06 | 268 | 134 | 9 | 33640491 | ||
| Pubmed | DMXL2 MIA3 EAPP RPLP0 RPLP2 UBR4 BMS1 DNAJC21 NCL SMARCAD1 ADCY9 EFTUD2 MDN1 CEBPZ RRP12 EHMT1 LTV1 PRKCSH PEAK1 EPB41L2 | 1.13e-06 | 1487 | 134 | 20 | 33957083 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | CNOT10 MED14 CHD8 ZC3H18 MDN1 RRP12 SMARCE1 AATF CAVIN1 TAF1 TNNC1 EPB41L2 | 1.15e-06 | 533 | 134 | 12 | 30554943 |
| Pubmed | 1.19e-06 | 272 | 134 | 9 | 31010829 | ||
| Pubmed | 1.56e-06 | 281 | 134 | 9 | 26725010 | ||
| Pubmed | UIMC1 STAG1 MED14 HEXIM1 DDX46 MDN1 ZC3H4 ANLN PHF3 SMARCE1 BOD1L1 | 1.59e-06 | 453 | 134 | 11 | 29656893 | |
| Pubmed | RPLP0 MAP1B USP9X UBR4 BMS1 PSMD3 NCL FRYL EFTUD2 ZC3H4 ANLN TASOR | 1.62e-06 | 551 | 134 | 12 | 34728620 | |
| Pubmed | UIMC1 NCOA6 STAG1 BMS1 DNAJC21 CHD8 ZC3H4 ANLN PHF3 NUCKS1 CPSF2 | 2.35e-06 | 472 | 134 | 11 | 38943005 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | MAP1B RPLP2 DTNB UBR4 PSMD3 EFTUD2 RRP12 PPME1 PRKCSH PEAK1 CDC25C UTRN | 2.43e-06 | 573 | 134 | 12 | 28330616 |
| Pubmed | DMXL2 RPLP0 RPLP1 MAP1B USP9X GEMIN5 PSMD3 NCL MAPK8IP3 EHD3 SPTBN4 KCNA1 SYNJ1 CADPS OSBPL10 PEAK1 UTRN EPB41L2 DMTN | 2.60e-06 | 1431 | 134 | 19 | 37142655 | |
| Pubmed | DMXL2 RPLP0 MAP1B CNOT10 UBR4 PACSIN3 DNAJC21 ZBTB7A C17orf75 MDN1 SYNJ1 PHF3 TAF1L | 2.85e-06 | 689 | 134 | 13 | 36543142 | |
| Pubmed | RPLP0 RPLP1 RPLP2 BMS1 MAK16 WDR55 PSMD3 NCL CEBPZ RRP12 AATF | 2.93e-06 | 483 | 134 | 11 | 36912080 | |
| Pubmed | 3.64e-06 | 399 | 134 | 10 | 37536630 | ||
| Pubmed | RPLP0 MAP7D3 MAP1B USP9X PSMD3 CC2D1B ZC3H18 ADCY9 RABL6 BOD1L1 LTV1 PEAK1 EPB41L2 | 3.83e-06 | 708 | 134 | 13 | 39231216 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | UIMC1 STAG1 NASP CHD8 ZC3H18 SMARCAD1 ANLN PHF3 EHMT1 SMARCE1 BOD1L1 TAF1 | 4.45e-06 | 608 | 134 | 12 | 36089195 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MIA3 MAP1B DTNB RTF2 RPS6KB1 NAIP FRYL BRWD3 STAT5B MAPK8IP3 EHD3 SPTBN4 ZBTB7A PLEKHG3 NEMF EHMT1 BOD1L1 CSMD1 UTRN | 4.61e-06 | 1489 | 134 | 19 | 28611215 |
| Pubmed | MIA3 SALL3 RPS6KB1 NASP GEMIN5 FRYL EHD3 PPARGC1A SYNJ1 ANLN AATF BOD1L1 PEAK1 CPSF2 TASOR UTRN | 4.63e-06 | 1084 | 134 | 16 | 11544199 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CAAP1 MAP7D3 MAP1B CNOT10 DNAJC21 GEMIN5 STK3 CEBPZ ZC3H4 PHF3 EHMT1 AATF CAVIN1 | 4.87e-06 | 724 | 134 | 13 | 36232890 |
| Pubmed | 5.10e-06 | 244 | 134 | 8 | 29884807 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | NCOA6 RPLP0 MAP1B NAIP PSMD3 NCL EHD3 KCNA1 SYNJ1 ACTR6 NUCKS1 EPB41L2 | 5.51e-06 | 621 | 134 | 12 | 22794259 |
| Pubmed | 5.60e-06 | 419 | 134 | 10 | 15635413 | ||
| Pubmed | CAAP1 RPLP1 SMARCAL1 BMS1 PACSIN3 MAK16 WDR55 NCL DDX46 CEBPZ PHF3 NEMF SMARCE1 AATF LTV1 CAVIN1 CPSF2 EPB41L2 | 5.71e-06 | 1371 | 134 | 18 | 36244648 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 UBR4 MED14 GEMIN5 CHD8 FRYL ADCY9 C8orf58 RYR1 MAPK8IP3 RABL6 MDN1 SYNJ1 RRP12 CTDP1 EHMT1 | 5.89e-06 | 1105 | 134 | 16 | 35748872 |
| Pubmed | 6.13e-06 | 116 | 134 | 6 | 21549307 | ||
| Pubmed | Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. | 6.58e-06 | 10 | 134 | 3 | 10983978 | |
| Pubmed | Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse. | 6.58e-06 | 10 | 134 | 3 | 11161808 | |
| Pubmed | SMG1 NCOA6 BMS1 CHD8 ADCY9 DDX46 MTUS1 ZC3H4 EHMT1 PLCB1 CPSF2 | 6.94e-06 | 529 | 134 | 11 | 14621295 | |
| Pubmed | DNAJC17 is localized in nuclear speckles and interacts with splicing machinery components. | 8.36e-06 | 71 | 134 | 5 | 29773831 | |
| Pubmed | 8.63e-06 | 347 | 134 | 9 | 17114649 | ||
| Pubmed | 8.99e-06 | 124 | 134 | 6 | 35516420 | ||
| Pubmed | 1.06e-05 | 451 | 134 | 10 | 30033366 | ||
| Pubmed | MIA3 RPLP0 MAP7D3 RPLP2 RTF2 UBR4 BMS1 GEMIN5 NCL SMARCAD1 ANLN NEMF EHMT1 BOD1L1 CAVIN1 PRKCSH EPB41L2 | 1.09e-05 | 1297 | 134 | 17 | 33545068 | |
| Interaction | MEN1 interactions | NCOA6 RPLP0 STAG1 RPLP2 SMARCAL1 UBR4 BMS1 MED14 PACSIN3 CHD8 ZC3H18 SMARCAD1 EFTUD2 DDX46 MDN1 CEBPZ ZC3H4 ANLN RRP12 EHMT1 SMARCE1 AATF BOD1L1 CAVIN1 TAF1 CPSF2 TASOR | 6.17e-10 | 1029 | 133 | 27 | int:MEN1 |
| Interaction | RPS19 interactions | RPLP0 RPLP1 MAP1B RPLP2 RPLP0P6 UBR4 BMS1 NCL ZC3H18 HEXIM1 EFTUD2 ZBTB7A CEBPZ ANLN RRP12 ATXN3 EHMT1 AATF LTV1 EPB41L2 | 7.56e-09 | 639 | 133 | 20 | int:RPS19 |
| Interaction | CSNK2A1 interactions | RPLP0 RPLP1 RPS6KB1 BMS1 MAK16 WDR55 NCL ZC3H18 SMARCAD1 BRWD3 HEXIM1 EFTUD2 ZC3H4 ANLN RRP12 CTDP1 EHMT1 NUCKS1 LTV1 CAVIN1 TAF1 CDC25C CCDC116 EPB41L2 | 1.51e-08 | 956 | 133 | 24 | int:CSNK2A1 |
| Interaction | SIRT7 interactions | RPLP0 RPLP1 MAP1B RPLP2 USP9X UBR4 BMS1 MAK16 GEMIN5 CHD8 NCL FRYL ZC3H18 DDX46 MDN1 CEBPZ PHF3 RRP12 AATF UTRN EPB41L2 | 1.85e-08 | 744 | 133 | 21 | int:SIRT7 |
| Interaction | SRP14 interactions | RPLP0 RPLP1 RPLP2 BMS1 MAK16 DNAJC21 NCL ZC3H18 HEXIM1 EFTUD2 CEBPZ ANLN RRP12 AATF CLSPN | 2.02e-08 | 366 | 133 | 15 | int:SRP14 |
| Interaction | HECTD1 interactions | MAP7D3 MAP1B RPLP0P6 USP9X BMS1 MED14 MAK16 DNAJC21 PSMD3 NCL EFTUD2 DDX46 MDN1 CEBPZ PHF3 RRP12 NEMF AATF LTV1 TAF1 CPSF2 CDC25C TASOR UTRN | 2.62e-08 | 984 | 133 | 24 | int:HECTD1 |
| Interaction | SMC5 interactions | UIMC1 NCOA6 CAAP1 SALL3 RPLP0 MAP7D3 MAP1B RPLP0P6 RTF2 CHD8 NCL ZC3H18 EFTUD2 DDX46 CEBPZ ZC3H4 ANLN PHF3 SMARCE1 AATF BOD1L1 TAF1 TASOR TAF1L | 3.55e-08 | 1000 | 133 | 24 | int:SMC5 |
| Interaction | H1-4 interactions | RPLP0 RPLP1 RPLP2 BMS1 MAK16 NCL ZC3H18 BRWD3 HEXIM1 RABL6 RNF113B MTUS1 CEBPZ ANLN PHF3 ACTR6 RRP12 AATF LTV1 | 6.35e-08 | 656 | 133 | 19 | int:H1-4 |
| Interaction | CHMP4B interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 USP9X BMS1 PACSIN3 CHMP4BP1 CC2D1B NCL ZC3H18 EFTUD2 SPTBN4 DDX46 ANLN PLEKHG3 CTDP1 SMARCE1 TAF1 STAG3 | 6.39e-08 | 727 | 133 | 20 | int:CHMP4B |
| Interaction | PARP1 interactions | UIMC1 NCOA6 RPLP0 STAG1 BMS1 MED14 NCL ZC3H18 SMARCAD1 HEXIM1 EFTUD2 RABL6 ZBTB7A MDN1 CEBPZ ANLN PHF3 RRP12 ATXN3 EHMT1 NUCKS1 SMARCE1 AATF CPSF2 CLSPN STAG3 EPB41L2 | 1.10e-07 | 1316 | 133 | 27 | int:PARP1 |
| Interaction | XRCC6 interactions | NCOA6 CAAP1 RPLP1 MAP1B BMS1 NASP PSMD3 CHD8 NCL ZC3H18 SMARCAD1 HEXIM1 EFTUD2 ZBTB7A DDX46 ZC3H4 ANLN PHF3 ATXN3 BOD1L1 TAF1 TAF1L | 1.77e-07 | 928 | 133 | 22 | int:XRCC6 |
| Interaction | RPL19 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 MAK16 WDR55 DNAJC21 NCL ZC3H18 HEXIM1 EFTUD2 CEBPZ ANLN RRP12 NEMF AATF LTV1 | 2.15e-07 | 638 | 133 | 18 | int:RPL19 |
| Interaction | RUVBL1 interactions | SMG1 EAPP MAP1B USP9X FBXW4 GEMIN5 PSMD3 CHD8 ZC3H18 SMARCAD1 HEXIM1 EFTUD2 ZBTB7A ANLN ACTR6 ATXN3 PPME1 | 2.50e-07 | 575 | 133 | 17 | int:RUVBL1 |
| Interaction | SNRPB interactions | CAAP1 EAPP USP9X GEMIN5 PSMD3 ZC3H18 SNUPN HEXIM1 EFTUD2 DDX46 ZC3H4 ANLN PHF3 CTDP1 CC2D2A TASOR | 3.16e-07 | 517 | 133 | 16 | int:SNRPB |
| Interaction | ECT2 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 USP9X PACSIN3 NCL USP9Y EFTUD2 SPTBN4 DDX46 CEBPZ ANLN PLEKHG3 RRP12 CTDP1 AATF BOD1L1 CAVIN1 CPSF2 STAG3 | 3.56e-07 | 887 | 133 | 21 | int:ECT2 |
| Interaction | PPIA interactions | UIMC1 NCOA6 SALL3 RPLP0 STAG1 MAP1B RPLP2 BMS1 DNAJC21 CHD8 HEATR5A ZC3H18 HEXIM1 EFTUD2 DDX46 ZC3H4 ANLN PHF3 ATXN3 NUCKS1 CPSF2 | 3.63e-07 | 888 | 133 | 21 | int:PPIA |
| Interaction | KIF20A interactions | RPLP0 RPLP1 RPLP2 MCF2L2 PACSIN3 CHD8 NCL ZC3H18 USP9Y CDC14A EFTUD2 SPTBN4 DDX46 PIEZO2 MIA2 ANLN CTDP1 NUCKS1 BOD1L1 CAVIN1 CPSF2 UTRN STAG3 | 3.75e-07 | 1052 | 133 | 23 | int:KIF20A |
| Interaction | SNRNP200 interactions | EAPP STAG1 MAP1B USP9X UBR4 NCL ZC3H18 CDC14A HEXIM1 EFTUD2 ANLN ATXN3 BOD1L1 LTV1 CAVIN1 | 3.92e-07 | 460 | 133 | 15 | int:SNRNP200 |
| Interaction | CHD4 interactions | SALL3 RPLP0 RPLP1 RPLP2 BMS1 NASP GEMIN5 NCL ZC3H18 SMARCAD1 HEXIM1 EFTUD2 RABL6 ZBTB7A DDX46 MDN1 RRP12 EHMT1 SMARCE1 PRKCSH CPSF2 | 8.82e-07 | 938 | 133 | 21 | int:CHD4 |
| Interaction | NIFK interactions | RPLP0 USP9X BMS1 MAK16 NCL ZC3H18 EFTUD2 MDN1 CEBPZ ANLN PHF3 RRP12 AATF CAVIN1 | 1.03e-06 | 431 | 133 | 14 | int:NIFK |
| Interaction | RPL17 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 MAK16 NCL ZC3H18 SNUPN HEXIM1 EFTUD2 CEBPZ ANLN RRP12 AATF LTV1 | 1.17e-06 | 571 | 133 | 16 | int:RPL17 |
| Interaction | RPS6 interactions | UIMC1 RPLP0 RPLP1 RPLP2 RPLP0P6 RPS6KB1 BMS1 MAK16 NCL ZC3H18 USP9Y HEXIM1 EFTUD2 CEBPZ ANLN RRP12 ATXN3 AATF LTV1 PRKCSH | 1.19e-06 | 874 | 133 | 20 | int:RPS6 |
| Interaction | SRSF6 interactions | RPLP0 RPLP1 RPLP2 USP9X BMS1 MAK16 ZC3H18 HEXIM1 EFTUD2 PPARGC1A CEBPZ ANLN RRP12 AATF LTV1 | 1.20e-06 | 503 | 133 | 15 | int:SRSF6 |
| Interaction | RPS16 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 DNAJC21 GEMIN5 NCL ZC3H18 USP20 HEXIM1 EFTUD2 ANLN RRP12 NEMF ATXN3 AATF LTV1 | 1.34e-06 | 724 | 133 | 18 | int:RPS16 |
| Interaction | RPL11 interactions | RPLP0 RPLP1 MAP1B RPLP2 RPLP0P6 BMS1 MAK16 NCL ZC3H18 HEXIM1 EFTUD2 CEBPZ ANLN NEMF AATF LTV1 CAVIN1 | 1.42e-06 | 652 | 133 | 17 | int:RPL11 |
| Interaction | RPS3A interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 USP9X BMS1 MAK16 NCL ZC3H18 HEXIM1 EFTUD2 ANLN RRP12 ATXN3 AATF LTV1 EPB41L2 | 1.51e-06 | 655 | 133 | 17 | int:RPS3A |
| Interaction | RPS2 interactions | RPLP0 RPLP1 MAP1B RPLP2 RPLP0P6 UBR4 BMS1 NCL ZC3H18 HEXIM1 EFTUD2 CEBPZ ANLN RRP12 ATXN3 AATF LTV1 | 1.58e-06 | 657 | 133 | 17 | int:RPS2 |
| Interaction | NAA40 interactions | UIMC1 RPLP0 MAP7D3 RPLP1 MAP1B NASP GEMIN5 NCL EFTUD2 DDX46 SYNJ1 ZC3H4 RRP12 NUCKS1 PPME1 SMARCE1 BOD1L1 LTV1 TASOR UTRN EPB41L2 | 1.72e-06 | 978 | 133 | 21 | int:NAA40 |
| Interaction | SUMO2 interactions | UIMC1 USP9X UBR4 GEMIN5 CHD8 NCL SMARCAD1 EFTUD2 MDN1 ANLN PHF3 EHMT1 BOD1L1 PRKCSH TAF1 CPSF2 | 1.83e-06 | 591 | 133 | 16 | int:SUMO2 |
| Interaction | RPS24 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 MAK16 NCL ZC3H18 HEXIM1 EFTUD2 CEBPZ ANLN RRP12 AATF LTV1 | 2.24e-06 | 529 | 133 | 15 | int:RPS24 |
| Interaction | RPS14 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 NCL ZC3H18 HEXIM1 EFTUD2 ZBTB7A CEBPZ ANLN RRP12 ATXN3 LTV1 | 2.24e-06 | 529 | 133 | 15 | int:RPS14 |
| Interaction | EFTUD2 interactions | EAPP RPLP0 RPLP1 RPLP2 USP9X RTF2 UBR4 PACSIN3 GEMIN5 PSMD3 NCL ZC3H18 SMARCAD1 HEXIM1 EFTUD2 CEBPZ ZC3H4 ANLN RRP12 NEMF ATXN3 SMARCE1 LTV1 CAVIN1 CPSF2 EPB41L2 | 2.51e-06 | 1449 | 133 | 26 | int:EFTUD2 |
| Interaction | RPL31 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 MAK16 NCL ZC3H18 HEXIM1 EFTUD2 CEBPZ ANLN RRP12 AATF LTV1 CAVIN1 TAF1 | 2.51e-06 | 680 | 133 | 17 | int:RPL31 |
| Interaction | GNL1 interactions | 2.56e-06 | 92 | 133 | 7 | int:GNL1 | |
| Interaction | AURKB interactions | MIA3 RPLP0 RPLP1 MAP1B RPLP2 UBR4 PSMD3 HEATR5A STK3 DDX46 ZC3H4 ANLN PLEKHG3 RRP12 CTDP1 LTV1 TAF1 UTRN | 2.70e-06 | 761 | 133 | 18 | int:AURKB |
| Interaction | CTAGE15 interactions | 2.78e-06 | 5 | 133 | 3 | int:CTAGE15 | |
| Interaction | KPNB1 interactions | MAP1B UBR4 CHD8 NCL SNUPN HEXIM1 EFTUD2 ANLN NEMF CTDP1 ATXN3 SMARCE1 LTV1 CAVIN1 CDC25C | 3.15e-06 | 544 | 133 | 15 | int:KPNB1 |
| Interaction | H2AC17 interactions | 3.30e-06 | 232 | 133 | 10 | int:H2AC17 | |
| Interaction | H2BC21 interactions | UIMC1 MAP1B SMARCAL1 DNAJC21 CC2D1B CHD8 NCL ZC3H18 USP20 HEXIM1 PPARGC1A ZC3H4 PHF3 ACTR6 EHMT1 NUCKS1 SMARCE1 | 3.43e-06 | 696 | 133 | 17 | int:H2BC21 |
| Interaction | PRPF8 interactions | EAPP RPLP0 RPLP1 MAP1B RPLP2 USP9X RTF2 UBR4 GEMIN5 NCL ZC3H18 CDC14A HEXIM1 EFTUD2 DDX46 ANLN ATXN3 BOD1L1 | 3.55e-06 | 776 | 133 | 18 | int:PRPF8 |
| Interaction | NPM1 interactions | RPLP0 RPLP1 MAP1B RPLP2 CNOT10 BMS1 MAK16 WDR55 GEMIN5 CHD8 NCL ZC3H18 CDC14A HEXIM1 EFTUD2 CEBPZ ANLN RRP12 ATXN3 AATF CAVIN1 CPSF2 UTRN | 3.60e-06 | 1201 | 133 | 23 | int:NPM1 |
| Interaction | SMARCA5 interactions | STAG1 NCL ZC3H18 SMARCAD1 HEXIM1 EHD3 EFTUD2 RABL6 ZBTB7A ANLN NUCKS1 CPSF2 EPB41L2 | 3.79e-06 | 415 | 133 | 13 | int:SMARCA5 |
| Interaction | RPL10 interactions | RPLP0 RPLP1 MAP1B RPLP2 RPLP0P6 CNOT10 PACSIN3 DNAJC21 NCL ZC3H18 HEXIM1 EFTUD2 ANLN RRP12 NEMF AATF LTV1 | 3.84e-06 | 702 | 133 | 17 | int:RPL10 |
| Interaction | SIRT6 interactions | SMG1 MIA3 RPLP0 RPLP2 USP9X MED14 GEMIN5 CHD8 NCL EFTUD2 CEBPZ PHF3 ACTR6 RRP12 EHMT1 AATF | 3.99e-06 | 628 | 133 | 16 | int:SIRT6 |
| Interaction | RPS13 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 PSMD3 NCL ZC3H18 HEXIM1 EFTUD2 ANLN RRP12 ATXN3 LTV1 | 4.47e-06 | 489 | 133 | 14 | int:RPS13 |
| Interaction | POLR1G interactions | UBR4 BMS1 CHD8 NCL ZC3H18 SMARCAD1 MDN1 CEBPZ PHF3 RRP12 EHMT1 AATF TAF1 CLSPN | 4.47e-06 | 489 | 133 | 14 | int:POLR1G |
| Interaction | RPS10 interactions | RPLP0 MAP7D3 RPLP1 RPLP2 RPLP0P6 BMS1 NCL ZC3H18 USP20 HEXIM1 EFTUD2 ANLN RRP12 AATF LTV1 | 5.20e-06 | 567 | 133 | 15 | int:RPS10 |
| Interaction | CDC42 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 USP9X RPS6KB1 PACSIN3 NASP PSMD3 NCL FRYL ZC3H18 ADCY9 EHD2 RABL6 MDN1 CEBPZ ZC3H4 ANLN PLEKHG3 OSBPL10 CAVIN1 PEAK1 UTRN | 5.42e-06 | 1323 | 133 | 24 | int:CDC42 |
| Interaction | CTAGE6 interactions | 5.54e-06 | 6 | 133 | 3 | int:CTAGE6 | |
| Interaction | CTAGE8 interactions | 5.54e-06 | 6 | 133 | 3 | int:CTAGE8 | |
| Interaction | RBBP4 interactions | SALL3 RPLP0 STAG1 NASP GEMIN5 PSMD3 ZC3H18 HEXIM1 STAT5B EFTUD2 ANLN ATXN3 NUCKS1 SMARCE1 CPSF2 | 5.91e-06 | 573 | 133 | 15 | int:RBBP4 |
| Interaction | NR3C1 interactions | SMG1 NCOA6 MAP7D3 USP9X SMARCAL1 UBR4 MED14 NCL RYR1 STAT5A STAT5B PPARGC1A C17orf75 MDN1 ANLN EHMT1 PLCB1 SMARCE1 AATF LTV1 | 6.10e-06 | 974 | 133 | 20 | int:NR3C1 |
| Interaction | MTA2 interactions | STAG1 RPLP2 NASP SMARCAD1 RFX3 HEXIM1 EFTUD2 RABL6 ZBTB7A ANLN NUCKS1 SMARCE1 CPSF2 | 6.31e-06 | 435 | 133 | 13 | int:MTA2 |
| Interaction | ILF3 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 CNOT10 BMS1 GON4L PSMD3 NCL ZC3H18 SMARCAD1 HEXIM1 EFTUD2 CEBPZ ANLN RRP12 NUCKS1 AATF CAVIN1 | 6.77e-06 | 896 | 133 | 19 | int:ILF3 |
| Interaction | MAD2L1 interactions | GEMIN5 CHD8 SMARCAD1 DDX46 ACTR6 CTDP1 ATXN3 EHMT1 BOD1L1 PEAK1 | 6.86e-06 | 252 | 133 | 10 | int:MAD2L1 |
| Interaction | H2AB2 interactions | 7.01e-06 | 107 | 133 | 7 | int:H2AB2 | |
| Interaction | SNRNP70 interactions | CAAP1 RPLP0 RPLP1 MAP1B RPLP2 USP9X BMS1 GEMIN5 NCL ZC3H18 HEXIM1 EFTUD2 RABL6 ZC3H4 PLEKHG3 RRP12 CTDP1 LTV1 CPSF2 EPB41L2 | 7.09e-06 | 984 | 133 | 20 | int:SNRNP70 |
| Interaction | RPL22 interactions | RPLP0 RPLP1 MAP1B RPLP2 RPLP0P6 NCL ZC3H18 HEXIM1 EFTUD2 CEBPZ ANLN NUCKS1 AATF | 7.13e-06 | 440 | 133 | 13 | int:RPL22 |
| Interaction | H3C1 interactions | UIMC1 STAG1 RTF2 UBR4 MED14 WDR55 NASP PSMD3 CHD8 EFTUD2 PIEZO2 ZC3H4 ANLN PHF3 RRP12 EHMT1 NUCKS1 LTV1 TAF1 | 7.33e-06 | 901 | 133 | 19 | int:H3C1 |
| Interaction | RPS20 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 GEMIN5 NCL ZC3H18 HEXIM1 EFTUD2 CEBPZ ANLN ATXN3 AATF LTV1 | 7.71e-06 | 513 | 133 | 14 | int:RPS20 |
| Interaction | SIN3A interactions | MAP1B UBR4 GON4L SMARCAD1 EFTUD2 ZBTB7A DDX46 CTDP1 SMARCE1 BOD1L1 TAF1 CPSF2 | 8.40e-06 | 380 | 133 | 12 | int:SIN3A |
| Interaction | RPL13A interactions | RPLP0 RPLP1 MAP1B RPLP2 UBR4 BMS1 MAK16 NCL ZC3H18 EFTUD2 CEBPZ ZC3H4 ANLN AATF BOD1L1 | 8.55e-06 | 591 | 133 | 15 | int:RPL13A |
| Interaction | JMJD6 interactions | 8.97e-06 | 205 | 133 | 9 | int:JMJD6 | |
| Interaction | RPSA interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 MAK16 ZC3H18 HEXIM1 EFTUD2 ANLN RRP12 ATXN3 AATF LTV1 | 9.38e-06 | 522 | 133 | 14 | int:RPSA |
| Interaction | NPM3 interactions | 9.65e-06 | 262 | 133 | 10 | int:NPM3 | |
| Interaction | CHD3 interactions | RPLP0 RPLP1 RPLP2 NCL ZC3H18 HEXIM1 EFTUD2 ZBTB7A DDX46 MDN1 CEBPZ RRP12 SMARCE1 AATF TAF1 CPSF2 EPB41L2 | 1.03e-05 | 757 | 133 | 17 | int:CHD3 |
| Interaction | RPL7A interactions | UIMC1 RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 MAK16 DNAJC21 NCL ZC3H18 USP20 HEXIM1 EFTUD2 CEBPZ ANLN AATF | 1.06e-05 | 679 | 133 | 16 | int:RPL7A |
| Interaction | MECP2 interactions | CAAP1 DMXL2 RPLP0 MAP1B RPLP2 BMS1 MED14 NCL ZC3H18 USP9Y HEXIM1 EFTUD2 DDX46 CEBPZ ZC3H4 ANLN RRP12 NEMF EHMT1 NUCKS1 SMARCE1 CPSF2 EPB41L2 | 1.12e-05 | 1287 | 133 | 23 | int:MECP2 |
| Interaction | RPL4 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 MAK16 DNAJC21 GEMIN5 NCL ZC3H18 SMARCAD1 EFTUD2 STK3 CEBPZ ANLN RRP12 AATF | 1.17e-05 | 764 | 133 | 17 | int:RPL4 |
| Interaction | MYBBP1A interactions | RPLP0 RPLP2 BMS1 MAK16 NCL ZC3H18 EFTUD2 PPARGC1A ZBTB7A CEBPZ ANLN AATF CAVIN1 | 1.23e-05 | 463 | 133 | 13 | int:MYBBP1A |
| Interaction | C7orf50 interactions | 1.47e-05 | 218 | 133 | 9 | int:C7orf50 | |
| Interaction | NEIL1 interactions | 1.52e-05 | 276 | 133 | 10 | int:NEIL1 | |
| Interaction | RPL13 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 MAK16 NCL ZC3H18 CDC14A USP20 HEXIM1 EFTUD2 CEBPZ ANLN RRP12 AATF | 1.55e-05 | 700 | 133 | 16 | int:RPL13 |
| Interaction | RPL30 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 MAK16 NCL ZC3H18 HEXIM1 EFTUD2 CEBPZ ANLN NEMF | 1.57e-05 | 474 | 133 | 13 | int:RPL30 |
| Interaction | GSK3B interactions | MIA3 RPLP0 MAP7D3 RPLP1 MAP1B NCL EFTUD2 SPTBN4 PPARGC1A MTUS1 CEBPZ ATXN3 LTV1 CAVIN1 PRKCSH PEAK1 CLSPN UTRN | 1.63e-05 | 868 | 133 | 18 | int:GSK3B |
| Interaction | TERF2IP interactions | UIMC1 NCOA6 PACSIN3 NASP CHD8 ZC3H18 ZC3H4 ANLN PHF3 NUCKS1 BOD1L1 TAF1 CLSPN TASOR | 1.75e-05 | 552 | 133 | 14 | int:TERF2IP |
| Interaction | PURG interactions | 1.76e-05 | 223 | 133 | 9 | int:PURG | |
| Interaction | DDX23 interactions | CAAP1 EAPP MAP1B BMS1 NCL ZC3H18 EFTUD2 DDX46 CEBPZ PHF3 RRP12 AATF TAF1 | 1.79e-05 | 480 | 133 | 13 | int:DDX23 |
| Interaction | ZNF668 interactions | 1.95e-05 | 226 | 133 | 9 | int:ZNF668 | |
| Interaction | RPL35 interactions | RPLP0 RPLP1 RPLP2 BMS1 MAK16 NCL ZC3H18 HEXIM1 EFTUD2 CEBPZ ANLN RRP12 AATF LTV1 | 1.97e-05 | 558 | 133 | 14 | int:RPL35 |
| Interaction | BIRC3 interactions | RPLP0 RPLP1 RPLP2 USP9X UBR4 BMS1 MAK16 NASP GEMIN5 PSMD3 NCL SMARCAD1 EFTUD2 MDN1 CEBPZ RRP12 EHMT1 NUCKS1 CC2D2A SMARCE1 PRKCSH PEAK1 EPB41L2 | 1.99e-05 | 1334 | 133 | 23 | int:BIRC3 |
| Interaction | RFC4 interactions | 2.02e-05 | 227 | 133 | 9 | int:RFC4 | |
| Interaction | HMGB1 interactions | RPLP0 MAP1B RPLP2 NASP NCL ZC3H18 HEXIM1 EFTUD2 ANLN CTDP1 SMARCE1 CAVIN1 TAF1 | 2.04e-05 | 486 | 133 | 13 | int:HMGB1 |
| Interaction | NOP2 interactions | RPLP0 RPLP2 RPLP0P6 BMS1 MAK16 ZC3H18 CDC14A EFTUD2 CEBPZ ANLN CC2D2A AATF | 2.07e-05 | 416 | 133 | 12 | int:NOP2 |
| Interaction | DDX21 interactions | RPLP0 MAP1B RPLP2 BMS1 MAK16 GEMIN5 NCL ZC3H18 HEXIM1 EFTUD2 ZBTB7A CEBPZ ANLN RRP12 AATF PRKCSH | 2.11e-05 | 718 | 133 | 16 | int:DDX21 |
| Interaction | POLR1E interactions | BMS1 CHD8 NCL SMARCAD1 MDN1 CEBPZ ANLN RRP12 EHMT1 AATF TAF1 | 2.12e-05 | 350 | 133 | 11 | int:POLR1E |
| Interaction | PRC1 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 PSMD3 NCL ZC3H18 EFTUD2 SPTBN4 DDX46 CEBPZ ANLN RRP12 CTDP1 AATF CAVIN1 STAG3 EPB41L2 | 2.15e-05 | 973 | 133 | 19 | int:PRC1 |
| Interaction | RPS3 interactions | RPLP0 RPLP1 MAP1B RPLP2 RPLP0P6 BMS1 NCL ZC3H18 HEXIM1 EFTUD2 ANLN RRP12 ATXN3 NUCKS1 AATF LTV1 | 2.22e-05 | 721 | 133 | 16 | int:RPS3 |
| Interaction | RPL3 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 BMS1 MAK16 WDR55 NCL ZC3H18 USP20 HEXIM1 EFTUD2 CEBPZ ANLN RRP12 AATF | 2.26e-05 | 722 | 133 | 16 | int:RPL3 |
| Interaction | IMPDH2 interactions | MAP1B RPLP2 RPLP0P6 RPS6KB1 UBR4 GEMIN5 PSMD3 STAT5B EFTUD2 SYNJ1 ANLN ATXN3 | 2.27e-05 | 420 | 133 | 12 | int:IMPDH2 |
| Interaction | FTSJ3 interactions | RPLP0 MAK16 WDR55 NCL ZC3H18 HEXIM1 EFTUD2 ANLN RRP12 AATF LTV1 TAF1 | 2.38e-05 | 422 | 133 | 12 | int:FTSJ3 |
| Interaction | CIT interactions | RPLP0 RPLP1 STAG1 RPLP2 RPLP0P6 UBR4 BMS1 MAK16 CHD8 HEATR5A NCL EFTUD2 SPTBN4 DDX46 CEBPZ ANLN RRP12 CTDP1 PPME1 AATF CACNA1I BOD1L1 CPSF2 STAG3 | 2.49e-05 | 1450 | 133 | 24 | int:CIT |
| Interaction | RPS8 interactions | RPLP0 RPLP1 RPLP2 RPLP0P6 PSMD3 NCL ZC3H18 HEXIM1 EFTUD2 ZBTB7A ANLN RRP12 ATXN3 AATF LTV1 | 2.56e-05 | 649 | 133 | 15 | int:RPS8 |
| Interaction | DCTN1 interactions | MAP7D3 MED14 PACSIN3 FBXW4 NASP DNAJC21 CC2D1B HEXIM1 MAPK8IP3 EFTUD2 MTUS1 LTV1 PRKCSH | 2.58e-05 | 497 | 133 | 13 | int:DCTN1 |
| Interaction | SURF6 interactions | RPLP0 RPLP1 RPLP2 BMS1 MAK16 NCL ZC3H18 CEBPZ ANLN PLEKHG3 RRP12 AATF | 2.61e-05 | 426 | 133 | 12 | int:SURF6 |
| Interaction | KIFBP interactions | 2.63e-05 | 180 | 133 | 8 | int:KIFBP | |
| Interaction | SRP9 interactions | RPLP0 RPLP1 RPLP2 GEMIN5 CHD8 NCL ZC3H18 HEXIM1 EFTUD2 CC2D2A CLSPN EPB41L2 | 2.67e-05 | 427 | 133 | 12 | int:SRP9 |
| Interaction | FZR1 interactions | SMG1 RPLP0 RPLP1 MAP1B RPLP2 USP9X BMS1 NASP DNAJC21 PSMD3 CHD8 NCL ZC3H18 CDC14A EFTUD2 CEBPZ ZC3H4 ANLN LTV1 CPSF2 CLSPN | 2.73e-05 | 1172 | 133 | 21 | int:FZR1 |
| Interaction | ARRDC2 interactions | 2.83e-05 | 54 | 133 | 5 | int:ARRDC2 | |
| Interaction | POLDIP3 interactions | 2.84e-05 | 237 | 133 | 9 | int:POLDIP3 | |
| GeneFamily | CTAGE family | 4.70e-05 | 15 | 87 | 3 | 907 | |
| GeneFamily | EF-hand domain containing | 8.94e-05 | 219 | 87 | 7 | 863 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.77e-04 | 206 | 87 | 6 | 682 | |
| GeneFamily | Cohesin complex | 6.29e-04 | 8 | 87 | 2 | 1060 | |
| GeneFamily | WD repeat domain containing | 1.66e-03 | 262 | 87 | 6 | 362 | |
| GeneFamily | L ribosomal proteins | 1.90e-03 | 51 | 87 | 3 | 729 | |
| GeneFamily | Ubiquitin specific peptidases | 2.48e-03 | 56 | 87 | 3 | 366 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.33e-03 | 18 | 87 | 2 | 91 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CETN3 USP9X NCL SMARCAD1 PPARGC1A DDX46 PIEZO2 MTUS1 CEBPZ ANLN PHF3 NEMF ATXN3 OSBPL10 TASOR | 1.17e-06 | 656 | 132 | 15 | M18979 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | NCOA6 PRRX1 NASP GON4L FRYL MIA2 CTAGE1 NUCKS1 PRKCSH TAF1 TASOR TAF1L | 6.46e-06 | 484 | 132 | 12 | MM999 |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_UP | 8.20e-06 | 200 | 132 | 8 | M3378 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 8.20e-06 | 200 | 132 | 8 | M9889 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | NCOA6 EAPP STAG1 CETN3 USP9X MED14 USP9Y NFU1 DDX46 PHF3 NEMF | 1.17e-05 | 429 | 132 | 11 | M29 |
| Coexpression | HELLER_SILENCED_BY_METHYLATION_DN | 1.73e-05 | 107 | 132 | 6 | M3185 | |
| Coexpression | BENPORATH_CYCLING_GENES | DMXL2 STAG1 CNOT10 NASP SNUPN STAT5B ZBTB7A MZF1 ANLN NUCKS1 CLSPN CDC25C STAG3 | 2.50e-05 | 648 | 132 | 13 | M8156 |
| Coexpression | GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 6.50e-05 | 197 | 132 | 7 | M8165 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | PRRX1 MIA3 MAP1B RPS6KB1 NCL HEXIM1 STK3 NEMF NUCKS1 UTRN EPB41L2 | 6.62e-05 | 519 | 132 | 11 | M3395 |
| Coexpression | GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 6.71e-05 | 198 | 132 | 7 | M4247 | |
| Coexpression | GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP | 6.92e-05 | 199 | 132 | 7 | M3262 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN | 6.92e-05 | 199 | 132 | 7 | M3836 | |
| Coexpression | GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP | 7.15e-05 | 200 | 132 | 7 | M8099 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_UP | 7.15e-05 | 200 | 132 | 7 | M4817 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP | 7.15e-05 | 200 | 132 | 7 | M7898 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | NCOA6 RPLP2 RPS6KB1 BMS1 MAK16 NASP PSMD3 NCL CDC14A STAT5A CEP68 DDX46 KCNA1 CEBPZ ZC3H4 PHF3 ATXN3 AATF TAF1 | 7.26e-05 | 1394 | 132 | 19 | M9585 |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS | 8.33e-05 | 356 | 132 | 9 | M43609 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.30e-04 | 466 | 132 | 10 | M13522 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.32e-04 | 467 | 132 | 10 | M1347 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.47e-04 | 384 | 132 | 9 | M1865 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NCOA6 CAAP1 USP9X RPS6KB1 MED14 MAK16 WDR55 NASP DNAJC21 FHOD3 NCL SMARCAD1 CDC14A RABL6 DDX46 MDN1 ANLN PHF3 NEMF SMARCE1 BOD1L1 CPSF2 CLSPN CDC25C | 5.88e-07 | 1257 | 130 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NCOA6 CAAP1 DMXL2 MAP1B USP9X MED14 NASP DNAJC21 GON4L FHOD3 NCL PPARGC1A C17orf75 DDX46 CEBPZ NEMF CC2D2A BOD1L1 CLSPN | 7.46e-07 | 831 | 130 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NCOA6 CAAP1 MAP1B USP9X RPS6KB1 MED14 MAK16 WDR55 NASP DNAJC21 FHOD3 NCL SMARCAD1 CDC14A RABL6 DDX46 MDN1 ANLN PHF3 NEMF SMARCE1 BOD1L1 CPSF2 CLSPN CDC25C | 2.37e-06 | 1459 | 130 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | MAP1B FHOD3 HEATR5A RFX3 PPARGC1A ANLN PHF3 NEMF CPSF2 CDC25C | 4.53e-06 | 259 | 130 | 10 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | MAP1B NASP FHOD3 HEATR5A NCL SMARCAD1 RFX3 DDX46 MIA2 CEBPZ ANLN PHF3 NEMF CLSPN | 4.95e-06 | 532 | 130 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CAAP1 SALL3 MAP7D3 MAP1B NASP DNAJC21 FHOD3 NCL FRYL PPARGC1A DDX46 NEMF CLSPN | 1.20e-05 | 498 | 130 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.33e-05 | 232 | 130 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.22e-05 | 311 | 130 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | NCOA6 PRRX1 USP9X FBXW4 WDR55 NASP DNAJC21 NCL SMARCAD1 RFX3 CDC14A BRWD3 C8orf58 DDX46 MDN1 MIA2 SMARCE1 BOD1L1 TNNC1 CLSPN CD180 | 2.36e-05 | 1252 | 130 | 21 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | SMG1 DMXL2 DTNB NASP DNAJC21 GEMIN5 CHD8 CDC14A RYR1 SYNJ1 ACTR6 STK39 PEAK1 UTRN STAG3 EPB41L2 | 2.91e-05 | 795 | 130 | 16 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.97e-05 | 333 | 130 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.48e-05 | 209 | 130 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.52e-05 | 225 | 130 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 9.04e-05 | 231 | 130 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 9.35e-05 | 298 | 130 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NCOA6 CAAP1 SALL3 MAP7D3 MAP1B MED14 NASP DNAJC21 FHOD3 NCL FRYL PPARGC1A DDX46 CEBPZ NEMF BOD1L1 CLSPN | 1.14e-04 | 989 | 130 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | DMXL2 RPLP2 BMS1 GEMIN5 HEATR5A EFTUD2 MDN1 ANLN ACTR6 RRP12 AATF LTV1 TAF1 CLSPN STAG3 | 1.33e-04 | 810 | 130 | 15 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | WDR55 NASP HEATR5A NCL DDX46 CEBPZ ANLN NEMF TNNC1 CLSPN CDC25C | 1.49e-04 | 469 | 130 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.51e-04 | 186 | 130 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | DMXL2 RPLP2 USP9X BMS1 MAK16 DNAJC21 HEATR5A EFTUD2 MDN1 ANLN AATF LTV1 TAF1 CLSPN STAG3 | 1.56e-04 | 822 | 130 | 15 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MAP1B PACSIN3 NASP DNAJC21 FHOD3 CHD8 USP20 PPARGC1A DDX46 MTUS1 CEBPZ NEMF CLSPN | 1.92e-04 | 654 | 130 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | PRRX1 USP9X MAK16 WDR55 NASP DNAJC21 FHOD3 NCL SMARCAD1 BRWD3 RABL6 DDX46 MDN1 ACTR6 NEMF SMARCE1 BOD1L1 CLSPN CDC25C | 1.99e-04 | 1241 | 130 | 19 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.38e-04 | 266 | 130 | 8 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | MAP1B MED14 NASP DNAJC21 FHOD3 FRYL SMARCAD1 RFX3 CDC14A BRWD3 PPARGC1A SYNJ1 CADPS PHF3 EHMT1 BOD1L1 STK39 CLSPN CADPS2 CDC25C | 2.50e-04 | 1370 | 130 | 20 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SMG1 DMXL2 DTNB NASP DNAJC21 GEMIN5 CHD8 CDC14A SYNJ1 ACTR6 STK39 UTRN STAG3 EPB41L2 | 2.93e-04 | 776 | 130 | 14 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | DMXL2 RPLP2 BMS1 MAK16 HEATR5A EFTUD2 MDN1 CEBPZ ANLN ACTR6 AATF LTV1 CLSPN STAG3 | 3.73e-04 | 795 | 130 | 14 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | EAPP RPS6KB1 MED14 NASP NCL BRWD3 PPARGC1A DDX46 ZC3H4 BOD1L1 TAF1 CLSPN | 4.93e-04 | 629 | 130 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 5.34e-04 | 61 | 130 | 4 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.46e-04 | 230 | 130 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 9.02e-08 | 184 | 134 | 8 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.80e-08 | 186 | 134 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID-19-Heart-Mito_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.15e-07 | 190 | 134 | 8 | ea74e0e38bcaba125b48c88331e9ba09228d3178 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.65e-07 | 199 | 134 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.19e-07 | 169 | 134 | 7 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.19e-07 | 169 | 134 | 7 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.19e-07 | 169 | 134 | 7 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.92e-06 | 192 | 134 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.99e-06 | 193 | 134 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-06 | 195 | 134 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | ASK440-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.20e-06 | 196 | 134 | 7 | 833723c8753922374cd7730907f1596899dd5734 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.28e-06 | 197 | 134 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.52e-06 | 200 | 134 | 7 | 7b7a5800798a3e7eba164fbc28312dd09c57a2c3 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 181 | 134 | 6 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 181 | 134 | 6 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 184 | 134 | 6 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 184 | 134 | 6 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.01e-05 | 184 | 134 | 6 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.01e-05 | 184 | 134 | 6 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 184 | 134 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.01e-05 | 184 | 134 | 6 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 2.20e-05 | 187 | 134 | 6 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 191 | 134 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.47e-05 | 191 | 134 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.47e-05 | 191 | 134 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 191 | 134 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.55e-05 | 192 | 134 | 6 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | E15.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.55e-05 | 192 | 134 | 6 | 4a0fb4ef8a9281489ffb0881421c9d691c52019c | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 192 | 134 | 6 | 5155f746ad57122ef735da776c96721005b8dadc | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 192 | 134 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.78e-05 | 195 | 134 | 6 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-05 | 195 | 134 | 6 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 195 | 134 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-05 | 195 | 134 | 6 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.86e-05 | 196 | 134 | 6 | c647ce58de4c5bb4ceb1123690e637eae4ae1b82 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.86e-05 | 196 | 134 | 6 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.94e-05 | 197 | 134 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-05 | 197 | 134 | 6 | e9327b133dab5f6a187cd8713f07205c948ec600 | |
| ToppCell | myeloid-CD34+_Monoblast|myeloid / Lineage and Cell class | 3.03e-05 | 198 | 134 | 6 | e26b98a8380e693110a97d8e5a353998f8d67c6d | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.03e-05 | 198 | 134 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.03e-05 | 198 | 134 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.03e-05 | 198 | 134 | 6 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-05 | 198 | 134 | 6 | 5d42f4fda2081ea3e9f62a00e7eea702e0d0be7d | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.11e-05 | 199 | 134 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 199 | 134 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.20e-05 | 200 | 134 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.20e-05 | 200 | 134 | 6 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | moderate-Lymphoid-NKT-proliferating|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.20e-05 | 200 | 134 | 6 | 8692e6664f0bb2be990f7563888380bb47414626 | |
| ToppCell | Endothelial-Endothelial-A|Endothelial / shred on cell class and cell subclass (v4) | 3.41e-05 | 122 | 134 | 5 | 65849d1296934d5765afd006cbb6739383b9f49f | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-04 | 160 | 134 | 5 | d8241404d775f9a709abdf17988f36293fcf4c58 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.26e-04 | 85 | 134 | 4 | 3f33e897eb030043905a6a1a83377cd601652958 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 169 | 134 | 5 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.73e-04 | 172 | 134 | 5 | 1aecc98a3eadabae0f1f328091a9733d916017ec | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.73e-04 | 172 | 134 | 5 | 5b1f6d4e09e6465acb80b58846ad387e38b155ab | |
| ToppCell | tumor_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 1.77e-04 | 173 | 134 | 5 | 934550c0290fb1058f353d97dba92757aeb2075e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-04 | 175 | 134 | 5 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-04 | 176 | 134 | 5 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 177 | 134 | 5 | 52402ff6299210c46fd9dee3cef203c0eda7a98a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.03e-04 | 178 | 134 | 5 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-04 | 178 | 134 | 5 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-04 | 178 | 134 | 5 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.03e-04 | 178 | 134 | 5 | 7975bf0a3146ee0efa4f547af5977e6bf0ba71fd | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.08e-04 | 179 | 134 | 5 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 180 | 134 | 5 | 978728c89497d26287f73974fb738ad9fde61415 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-04 | 181 | 134 | 5 | d909821355f4bc9e35387cda6ecf7c56793d9da4 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-04 | 181 | 134 | 5 | 9b155a74e68e485039a5195144a12833f2f75058 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-04 | 181 | 134 | 5 | 52935c496b45207a173b5ac7812f46210c3f74b0 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 182 | 134 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 182 | 134 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 182 | 134 | 5 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-04 | 183 | 134 | 5 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-B_memory|ICU-NoSEP / Disease, Lineage and Cell Type | 2.30e-04 | 183 | 134 | 5 | c6d1d0779c46e08d2235b6dd342a7ec25911864c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-04 | 183 | 134 | 5 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-04 | 185 | 134 | 5 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.42e-04 | 185 | 134 | 5 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 185 | 134 | 5 | 9de1db2ce9e44956b1214daf6e1e161334679c88 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 185 | 134 | 5 | 39f2b7a35253968f6d744c10ece1478a05cf24da | |
| ToppCell | droplet-Heart-nan-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 185 | 134 | 5 | c61267cfadea018794f7964904445787629a40d1 | |
| ToppCell | droplet-Heart-nan-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 185 | 134 | 5 | 3a592719d5643011954f89d5bb61a5e94682b68e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-lymphatic_endothelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 185 | 134 | 5 | 18f5d9438c76e37988a7d17aa2a080af6bedbfc4 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 186 | 134 | 5 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.48e-04 | 186 | 134 | 5 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 186 | 134 | 5 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 186 | 134 | 5 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.48e-04 | 186 | 134 | 5 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-04 | 186 | 134 | 5 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 187 | 134 | 5 | 376a95ac1e38f61f8db5d23d9a905f8dae8c40b6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 187 | 134 | 5 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 187 | 134 | 5 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 187 | 134 | 5 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.61e-04 | 188 | 134 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 188 | 134 | 5 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 188 | 134 | 5 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 188 | 134 | 5 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-04 | 189 | 134 | 5 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 189 | 134 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 189 | 134 | 5 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 190 | 134 | 5 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-04 | 190 | 134 | 5 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.81e-04 | 191 | 134 | 5 | 361b123c8289015206d5e706ab2c615d9a724179 | |
| Computational | Ttranslation elongation. | 5.11e-06 | 15 | 87 | 4 | MODULE_150 | |
| Drug | So-1 | 3.99e-06 | 41 | 133 | 5 | CID000447250 | |
| Drug | lead arsenate | 1.39e-05 | 89 | 133 | 6 | CID000024572 | |
| Drug | 5194442; Up 200; 20uM; PC3; HT_HG-U133A | 1.90e-05 | 194 | 133 | 8 | 6553_UP | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.90e-05 | 194 | 133 | 8 | 2238_DN | |
| Drug | (R)-(+)-Atenolol [56715-13-0]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.97e-05 | 195 | 133 | 8 | 2855_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.97e-05 | 195 | 133 | 8 | 1522_DN | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 1.97e-05 | 195 | 133 | 8 | 5455_DN | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; HL60; HG-U133A | 2.12e-05 | 197 | 133 | 8 | 1368_DN | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 6801_UP | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 2.20e-05 | 198 | 133 | 8 | 3537_DN | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; HL60; HG-U133A | 2.28e-05 | 199 | 133 | 8 | 1391_DN | |
| Drug | celecoxib; Down 200; 10uM; MCF7; HG-U133A | 2.28e-05 | 199 | 133 | 8 | 206_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.36e-05 | 200 | 133 | 8 | 2838_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 2.36e-05 | 200 | 133 | 8 | 1164_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.36e-05 | 200 | 133 | 8 | 3403_UP | |
| Drug | I-bB | 3.12e-05 | 62 | 133 | 5 | CID005326396 | |
| Drug | quizartinib | 5.34e-05 | 13 | 133 | 3 | ctd:C544967 | |
| Drug | Mfpa | 1.01e-04 | 3 | 133 | 2 | CID003035615 | |
| Drug | AC1L9LNU | 1.07e-04 | 80 | 133 | 5 | CID000448157 | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.13e-04 | 186 | 133 | 7 | 3851_DN | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.34e-04 | 191 | 133 | 7 | 5442_DN | |
| Drug | Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.38e-04 | 192 | 133 | 7 | 2873_DN | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.38e-04 | 192 | 133 | 7 | 4110_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.38e-04 | 192 | 133 | 7 | 6054_DN | |
| Drug | Succimer | SMG1 MIA3 USP9X RPS6KB1 NAIP DNAJC21 NCL EHD2 ZBTB7A DDX46 PIEZO2 CADPS PHF3 NEMF ATXN3 TNNC1 CLSPN UTRN EPB41L2 | 1.40e-04 | 1264 | 133 | 19 | ctd:D004113 |
| Drug | STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A | 1.43e-04 | 193 | 133 | 7 | 6869_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 4572_DN | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; MCF7; HT_HG-U133A | 1.47e-04 | 194 | 133 | 7 | 5342_UP | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 5447_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 3266_UP | |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 5257_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 5583_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 2229_DN | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 5636_DN | |
| Drug | 5151277; Down 200; 14uM; MCF7; HT_HG-U133A_EA | 1.57e-04 | 196 | 133 | 7 | 903_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 6060_DN | |
| Drug | Domperidone maleate; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 4640_DN | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 2887_DN | |
| Drug | LY294002; Down 200; 10uM; PC3; HG-U133A | 1.62e-04 | 197 | 133 | 7 | 429_DN | |
| Drug | Parbendazole [14255-87-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 4535_DN | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 3242_UP | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 5597_DN | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 2810_UP | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 133 | 7 | 1496_DN | |
| Drug | MBTS | 1.63e-04 | 47 | 133 | 4 | CID000008447 | |
| Drug | rofecoxib; Down 200; 10uM; MCF7; HG-U133A | 1.67e-04 | 198 | 133 | 7 | 166_DN | |
| Drug | Tridihexethyl chloride; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 5067_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 5944_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 1689_UP | |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 7163_DN | |
| Drug | Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 6362_DN | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 4087_DN | |
| Drug | Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 6036_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; HL60; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 2174_DN | |
| Drug | Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 6262_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 4765_DN | |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 3082_DN | |
| Drug | ICI 182,780; Down 200; 1uM; PC3; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 1205_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 4526_DN | |
| Drug | estradiol, USP; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.72e-04 | 199 | 133 | 7 | 988_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; HL60; HG-U133A | 1.72e-04 | 199 | 133 | 7 | 1588_DN | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; PC3; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 7518_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 1493_DN | |
| Drug | 5'IATR | 1.76e-04 | 19 | 133 | 3 | CID000074997 | |
| Drug | AZD 1480 | 2.02e-04 | 4 | 133 | 2 | ctd:C545606 | |
| Drug | methyl-1,4-benzoquinone | 2.08e-04 | 50 | 133 | 4 | CID000011122 | |
| Drug | Magnetite Nanoparticles | SMG1 MIA3 USP9X RPS6KB1 NAIP DNAJC21 NCL EHD2 ZBTB7A DDX46 PIEZO2 CADPS PHF3 NEMF ATXN3 TNNC1 CLSPN UTRN EPB41L2 | 2.21e-04 | 1310 | 133 | 19 | ctd:D058185 |
| Disease | Down syndrome (biomarker_via_orthology) | 1.90e-05 | 2 | 129 | 2 | DOID:14250 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | NCOA6 RPLP2 SMARCAL1 UBR4 MCF2L2 MED14 DNAJC21 JAKMIP3 STAT5A MIA2 EHMT1 PLCB1 BOD1L1 CAVIN1 PLD2 CLSPN | 1.92e-05 | 1074 | 129 | 16 | C0006142 |
| Disease | Episodic Ataxia | 1.13e-04 | 4 | 129 | 2 | C1720189 | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.32e-04 | 59 | 129 | 4 | EFO_0009658, GO_0009410 | |
| Disease | Intellectual Disability | 1.60e-04 | 447 | 129 | 9 | C3714756 | |
| Disease | JT interval | 7.98e-04 | 248 | 129 | 6 | EFO_0007885 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 8.05e-04 | 447 | 129 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Ceroid lipofuscinosis, neuronal 1, infantile | 8.34e-04 | 10 | 129 | 2 | C2931673 | |
| Disease | systolic blood pressure, self reported educational attainment | 8.34e-04 | 10 | 129 | 2 | EFO_0004784, EFO_0006335 | |
| Disease | neuroimaging measurement | STAG1 MAP1B FRYL SMARCAD1 MAPK8IP3 EFTUD2 PPARGC1A SYNJ1 CADPS NUCKS1 CC2D2A PRKCSH DMTN | 8.38e-04 | 1069 | 129 | 13 | EFO_0004346 |
| Disease | Macrocephaly | 1.02e-03 | 11 | 129 | 2 | C0221355 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 1.30e-03 | 49 | 129 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | Hypertrophic Cardiomyopathy | 2.01e-03 | 57 | 129 | 3 | C0007194 | |
| Disease | loneliness measurement | 2.18e-03 | 124 | 129 | 4 | EFO_0007865 | |
| Disease | spinal stenosis | 2.47e-03 | 17 | 129 | 2 | EFO_0007490 | |
| Disease | Tourette syndrome, schizophrenia | 2.77e-03 | 18 | 129 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 3.09e-03 | 19 | 129 | 2 | EFO_0002609, GO_0031427 | |
| Disease | Profound Mental Retardation | 3.29e-03 | 139 | 129 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 3.29e-03 | 139 | 129 | 4 | C0025363 | |
| Disease | Mental deficiency | 3.29e-03 | 139 | 129 | 4 | C0917816 | |
| Disease | body weight | GON4L CHD8 SNUPN RFX3 ADCY9 CADPS ANLN PHF3 NUCKS1 STK39 CPSF2 CADPS2 EPB41L2 | 3.58e-03 | 1261 | 129 | 13 | EFO_0004338 |
| Disease | temporal horn of lateral ventricle volume measurement | 3.91e-03 | 72 | 129 | 3 | EFO_0010333 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 4.14e-03 | 22 | 129 | 2 | cv:C0949658 | |
| Disease | venous thromboembolism | 4.19e-03 | 460 | 129 | 7 | EFO_0004286 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLAEAGVDEDEDLTM | 711 | Q13075 | |
| EGGKLISENDDFEDM | 361 | Q9GZN1 | |
| SMDKEVDDILGEGSD | 856 | Q9Y5B0 | |
| MEEDDEGSKFCEEDI | 1316 | Q9HCK8 | |
| MDNEGRDKAEIEDED | 581 | Q8IYX3 | |
| LKATEMVEVGADDDE | 336 | Q6NZI2 | |
| QAEMLTEDDDFEIGD | 2266 | Q96PZ7 | |
| DGVAMLEEDVTDDDN | 246 | Q96RT6 | |
| EEDITDDGNLELEMN | 91 | Q8IX95 | |
| DDGNLELEMNSELKD | 96 | Q8IX95 | |
| MALGEEKAEAEASED | 1 | Q76N32 | |
| GELKDDGEDSEMQVE | 651 | Q9P2I0 | |
| RFGEDNLEDDDVEMK | 376 | Q9UNH5 | |
| KLSDVDRDGMLDDEE | 491 | Q9NZN4 | |
| SSEDEFEKEMEAELN | 56 | Q56P03 | |
| LSASEEDENMGGEDK | 1576 | Q6RI45 | |
| DEDLGDMGEDEEAQF | 146 | Q9BSW2 | |
| ESMEADTDLEAGLEE | 156 | Q8NAV2 | |
| EEEADDGSKMGSDLV | 206 | Q9H8G2 | |
| LDEEEDDAVGLVMKS | 1986 | Q8TDJ6 | |
| GEKSDEDELMAELEE | 116 | P59074 | |
| EDIDDEDISSAMLKG | 256 | Q99467 | |
| EDDEMSEDDGLENGS | 446 | Q14692 | |
| AAEMGEDGEKEFQEE | 711 | Q96MT7 | |
| ESMKDLDEEQAGQTD | 1046 | Q9H0J4 | |
| QEAESEMALDAEFLD | 121 | Q3YEC7 | |
| DADEDSLAGELDEAM | 71 | Q8WXF3 | |
| ESMEDVEVENETGKD | 51 | Q9Y570 | |
| QEKDSGSDEDFLMED | 126 | Q9H1E3 | |
| GLQGISMKDSDEEDE | 1336 | Q9ULU8 | |
| VKDSQQDELDDLGEM | 236 | Q9NUD7 | |
| GMDEEDSELVAKDDN | 4801 | Q9NU22 | |
| SEDDKAEGEEEMDTG | 4946 | Q9NU22 | |
| ELGEEAMEKFREDEG | 121 | Q09470 | |
| GDDRAEEDMDEAIEK | 996 | P46821 | |
| EEDMDEAIEKGEAEQ | 1001 | P46821 | |
| TGEEEGMDIQKSENE | 171 | Q96GA3 | |
| VDESDISDFEDMDKL | 226 | Q9BXY0 | |
| DMDKLDASSDEDQDG | 236 | Q9BXY0 | |
| DDETEEGAGDMSQVK | 1301 | Q9UPT6 | |
| EGVEQVMDDESDEKE | 236 | Q9UMS0 | |
| QDSVGEMKDEGEETL | 761 | O60524 | |
| MTDDNSDDKIEDELQ | 1 | Q9ULD2 | |
| EDEVEKLMAGQEDSN | 166 | P08590 | |
| QELAADAFKELDDDM | 211 | P14314 | |
| DVLEEGELDMEKSQE | 571 | Q9NQW6 | |
| NDGSGMLDEDEEDLQ | 216 | P54252 | |
| AKSDDTSDDDFMEEG | 231 | O94992 | |
| EGALKQDMGEEAEEE | 831 | O43491 | |
| DTFEDCEGAEDMEKE | 1016 | Q86YR7 | |
| MEEAKSQSLEEDFEG | 1 | P20941 | |
| DDMEETEEDAKGETD | 1416 | Q9H792 | |
| LDVELEDAEGESMDN | 2431 | O94915 | |
| DDDLEEGMAKEETEL | 486 | Q5VZ66 | |
| EDELEEGGQLNESMD | 41 | P23443 | |
| EKEFGDGSDENEMEE | 276 | Q5F1R6 | |
| KEESEESDEDMGFGL | 301 | P05388 | |
| AKKEESEESDDDMGF | 96 | P05386 | |
| DEKKEESEESDDDMG | 96 | P05387 | |
| QESMDGDEKELESSE | 6 | Q9HAS0 | |
| MKEGEETEGSEEDDK | 471 | P49321 | |
| NLGEDQAEEISDELM | 181 | P30307 | |
| EDAKAAKEAMEDGEI | 621 | P19338 | |
| DQATLDDMEKSVNDD | 471 | O60244 | |
| AMDGLFDDSEDESDK | 506 | Q9UBK2 | |
| MDFDSGLEDDDTKSD | 26 | Q14686 | |
| DSMEEGEITSDDEEK | 431 | Q8NFC6 | |
| TMQEEEGDKGDDASV | 1186 | Q86XA9 | |
| GKEMDEEELLNGDDA | 236 | Q9P2K1 | |
| SEMDEFKNLDSDIEG | 3781 | Q9UFH2 | |
| SNKEAQEDAEMDAEL | 1736 | Q9P0X4 | |
| QDMDFTDLGEEDDID | 801 | Q2V2M9 | |
| EEEEEEAEGMESLQK | 1526 | Q3T8J9 | |
| ESLQKEDEMTDEAVG | 1536 | Q3T8J9 | |
| EDEMTDEAVGDSAEK | 1541 | Q3T8J9 | |
| LLGMDEAEDDEDLEA | 36 | Q5T0F9 | |
| EGAEEEEEKMQNGKD | 611 | O60941 | |
| IIADDLMKQGDEESE | 341 | O60503 | |
| GLQGITMKDSDEEEE | 1281 | Q86UW7 | |
| DEELRAMIEEFDKDG | 136 | O15182 | |
| AMIEEFDKDGDGEIN | 141 | O15182 | |
| MAAAAGEEEEEEEAA | 1 | P57775 | |
| ADNEESDKDSLNEMF | 746 | Q8IWC1 | |
| DEDDPAEAEKEGNEM | 206 | Q7L014 | |
| AEAEKEGNEMEGEEL | 211 | Q7L014 | |
| EEDDDSGEEMKALRE | 221 | Q08495 | |
| DENSMEDDAELKDAA | 801 | Q9BXA9 | |
| DRMIDDLSKAGEQEE | 3671 | P21817 | |
| DRAQKMDGESEEEQE | 386 | Q9H9B1 | |
| IDANDDEDMEKFTDA | 636 | Q03701 | |
| AGEELLKMSEEDEQG | 386 | Q9UKS6 | |
| MLDDRKNEEDGGADE | 396 | Q96PC5 | |
| EDDVIMLNGTKEDVD | 166 | Q9BY42 | |
| DDGDVTECKMDDDEE | 1901 | Q93008 | |
| DDLDADMKEAESVRN | 2701 | P46939 | |
| KEESEESDEDMGFGL | 301 | Q8NHW5 | |
| DKESGQEGVDSMAEE | 366 | Q969G3 | |
| KLEQDMTTVDEGDEG | 996 | Q9H4L7 | |
| EDAEVAADFDMEGDV | 1001 | O43426 | |
| DKTELEDENQEGMTV | 481 | Q5JRA6 | |
| EDMGATADFEQDTEK | 106 | Q8IZP6 | |
| GNLDKDEGSEVESEM | 666 | P48380 | |
| DLKALSSEEEEEMGG | 571 | A1L390 | |
| AEDSDFEEMGKNIEN | 1111 | Q8IZX4 | |
| SAEDSDFEEMGKNIE | 1091 | P21675 | |
| LLMSEGEDDEEDAGS | 1716 | P21675 | |
| AMAKDEEAALADGED | 3431 | Q96Q15 | |
| EKEGSDMELLEAAES | 891 | Q9NZC9 | |
| LDTDGDFDLEDTMDV | 751 | P51692 | |
| TGMESEEENKKDDEE | 71 | O95149 | |
| DKDGMLDDDEFALAN | 491 | Q9NZN3 | |
| DNEDKEETELGVMED | 381 | Q9BXB5 | |
| IREEADGNKMEEEEG | 1156 | Q5JTH9 | |
| LDQDGEFDLDETMDV | 746 | P42229 | |
| EKDEEDMSLDSGDEI | 1501 | Q9UK61 | |
| TKGMDDLGSSEEEED | 161 | Q9NY61 | |
| DEKEMDKENNDGSSE | 691 | Q9HAW4 | |
| SAVEEMDGLDDVENS | 96 | Q9H9A5 | |
| VINSEDEEEEDGTMK | 366 | Q13188 | |
| QQDLEFAKEMAEDDD | 516 | O43242 | |
| GLKEMEEEDGSELDF | 1121 | Q9UJ98 | |
| SMDDDEEESGAKVDS | 306 | Q12893 | |
| ESIDGNEEESMKENS | 756 | Q8TEQ6 | |
| GEGQDMQKLSEEDDE | 1506 | Q9H5I5 | |
| DDIMDEGVVKESGND | 86 | Q92576 | |
| DGSEFLLQAKDEEEM | 2501 | Q9H254 | |
| QSMEGDEEDEANKIE | 846 | Q8WVM7 | |
| DLHDDMFGDEKQDSE | 1596 | O00507 | |
| SDDDDDDDDCKKSSM | 511 | Q9NQ66 | |
| EDADVDTAMAALDDQ | 346 | Q9Y2K6 | |
| MLADDAEAGAEDEKE | 481 | Q9UPT8 | |
| GEDSMAQEEKEETGD | 366 | Q9H6Y2 | |
| MNLESDDEDGGEAEK | 31 | Q5T619 | |
| LGRETKDLDEMDDDD | 26 | Q15029 | |
| DLEEAGDMVAAQADE | 41 | P54821 | |
| DDEMDEKSEEGKAAF | 386 | Q9UEW8 | |
| RSNTPMGDKDDDDDD | 2721 | Q5T4S7 | |
| MGDKDDDDDDDADEK | 2726 | Q5T4S7 | |
| DDDDDDADEKMQSSG | 2731 | Q5T4S7 | |
| DDIEELMKDGDKNND | 131 | P63316 | |
| QMESDEVDTLKEGED | 21 | O14939 | |
| NECISEDMGDEDKEE | 346 | Q96RL1 | |
| DSDEESRADDKGVMD | 336 | O95365 | |
| AVQEDEAEKAGAEDD | 141 | Q86VM9 | |
| MVKLEDSEEEGEAAL | 21 | P28698 |